The Leadership Team at Dendreon Pharmaceuticals is responsible for steering the company's strategic direction and operational efficiency in the development of innovative cancer therapies. This diverse group collaborates across functions such as operations, legal compliance, patient engagement, business development, information technology, finance, and research to ensure alignment with the company’s mission of unleashing the immune system's potential to combat cancer. Their collective expertise drives decision-making processes that enhance patient outcomes and advance the company’s goals in personalized medicine.
Bruce Johnson
Vice President, IMF Operations
Cindy Staka PhD
Principal Scientist - Antigen/...
Fang Wang
Deputy Chief Financial Officer
Joy Wang
Vice President Of Business Dev...
Kevin Helmbacher
SVP of Legal and Compliance an...
Michael Allen
Vice president, Information Te...
Nadeem Sheikh
VP Research & Manufacturing Sc...
Serena Stewart
Vice President, Patient Operat...
View all